Inhibition of Autophagy Enhances Sunitinib-Induced Cytotoxicity in Rat Pheochromocytoma PC12 cells
Sunitinib is an oral multitargeted receptor tyrosine kinase inhibitor with antiangiogenic and antitumor activity that mainly targets vascular endothelial growth factor receptors, and recently, it has been shown to be an active agent for the treatment of malignant pheochromocytomas. Previously, we de...
Saved in:
Main Authors: | Tatsuhiko Ikeda (Author), Kiyo-aki Ishii (Author), Yuria Saito (Author), Masahiro Miura (Author), Aoi Otagiri (Author), Yasushi Kawakami (Author), Hitoshi Shimano (Author), Hisato Hara (Author), Kazuhiro Takekoshi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pheochromocytoma in pregnancy
by: Khushboo Bagdi Kasat, et al.
Published: (2021) -
Diagnosis of pheochromocytoma
by: Kalpana S Vora, et al.
Published: (2012) -
Sorafenib and sunitinib: A dermatologist's perspective
by: Vijendran Pragasam, et al.
Published: (2014) -
A Pilot Study of miRNA Expression Profile as a Liquid Biopsy for Full-Marathon Participants
by: Tomoaki Kuji, et al.
Published: (2021) -
Pheochromocytoma A New View of the Old Problem
Published: (2011)